Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells

The purpose of this study was to determine the potential benefits of combination therapy using dimercaptosuccinic acid modified iron oxide (DMSA-Fe(3)O(4)) magnetic nanoparticles (MNPs) combined with nontoxic concentration of bortezomib (BTZ) and gambogic acid (GA) on multiple myeloma (MM) RPMI-8226...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Qiao, Lixing, Wang, Xinchao, Senthilkumar, Ravichandran, Wang, Fei, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425315/
https://www.ncbi.nlm.nih.gov/pubmed/25995634
http://dx.doi.org/10.2147/IJN.S80795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425315/
https://www.ncbi.nlm.nih.gov/pubmed/25995634
http://dx.doi.org/10.2147/IJN.S80795

Ejemplares similares